Brain Tumor Therapeutics: Global Markets to 2023
The global brain tumor therapeutics market was valued at REDACTED in 2017 and is expected to witness a compound annual growth rate (CAGR) of REDACTED, to reach a value of REDACTED in 2023. The mortality rate of brain cancer in both adult and pediatric population is very high. According to the Global Cancer Observatory, around 241,037 patients are expected to die globally due to brain tumors in 2018. Therapeutic Nuclear Medicines Find Increased Applicability in Thyroid, Brain Cancer Treatment: Projects FMI Survey The median duration of patient survival of brain tumors is estima ted to be between 12 and 18 months with maximal treatment. Only 2-5% of patients survive for more than three years. KEY BENEFITS : -The Brain Tumor Therapeutics report will help to develop Business Strategies by understanding the trends shaping and driving Brain Tumor Therapeutics market. -To establish sales and marketing efforts by identifying the best opportunities for Brain Tumor Th...